OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Kuros N/  CH0325814116  /

SIX Swiss Exchange
2024-08-05  2:15:17 PM Chg. -1.500 Volume Bid2:15:40 PM Ask2:15:40 PM Market Capitalization Dividend Y. P/E Ratio
11.500CHF -11.54% 467,225
Turnover: 5.34 mill.		 11.440Bid Size: 771 11.500Ask Size: 1,345 418.99 mill.CHF - -
GlobeNewswire 2022-02-03 Kuros Biosciences’s MagnetOs Granules Cleared by FDA for Expanded Spinal Indications
GlobeNewswire 2021-10-26 Kuros Biosciences Reports Continued Increase in MagnetOs U.S. Sales
GlobeNewswire 2021-09-28 Kuros Biosciences to Showcase New MagnetOs Products at NASS 2021 Annual Meeting
GlobeNewswire 2021-07-15 Kuros to receive $7 million up front and potentially $166.5 million in future revenues under a royal...
GlobeNewswire 2021-07-15 XOMA Acquires Royalty and Milestone Interest in Checkmate’s Vidutolimod (CMP-001) from Kuros Bioscie...
GlobeNewswire 2021-03-18 Kuros Biosciences Reports Results for the Full Year 2020
GlobeNewswire 2021-03-10 Kuros Biosciences to Present at Upcoming Clinical and Investor Conferences
GlobeNewswire 2021-03-02 Kuros Biosciences Announces MagnetOs Sales and Distribution Agreements Across Northern Europe
GlobeNewswire 2020-09-09 CORRECTING AND REPLACING -- Kuros Biosciences’s Licensee Checkmate Pharmaceuticals Completes its IPO...
GlobeNewswire 2020-09-09 Kuros Biosciences’s licensee Checkmate Pharmaceuticals completes its IPO on NASDAQ
GlobeNewswire 2020-09-01 Kuros Biosciences Announces Treatment of the First Patient in its Spinal Fusion Trial with Fibrin-PT...
GlobeNewswire 2020-08-12 Kuros Biosciences Reports Results for First Half 2020
GlobeNewswire 2020-07-22 Kuros Biosciences Further Strengthens Orthobiologics Patent Portfolio
GlobeNewswire 2020-03-26 Kuros Biosciences Reports Results for the Full Year 2019
GlobeNewswire 2020-03-18 Kuros Strengthens Orthobiologics Patent Portfolio
GlobeNewswire 2020-02-03 Affimed Mourns Passing of Chief Financial Officer Dr. Florian Fischer
GlobeNewswire 2020-01-30 Kuros Reports Publication of MagnetOs Preclinical Data Demonstrating Superiority to Market-Leading S...
GlobeNewswire 2019-10-02 Kuros Biosciences to Host Key Opinion Leader Meeting in Zurich Showcasing its Commercial Stage Advan...
GlobeNewswire 2019-09-24 Kuros Biosciences announces full commercial launch of MagnetOs™ and exhibitor status at North Americ...
GlobeNewswire 2019-09-03 Kuros Biosciences Announces U.S. FDA approval of IND Application to Initiate Fibrin-PTH Phase 2a Cli...
GlobeNewswire 2019-08-20 Kuros Biosciences Reports Results for First Half 2019
GlobeNewswire 2019-07-09 Kuros Biosciences Signs Agreement with Surgical Specialties on Distribution of MagnetOs in Australia...
GlobeNewswire 2019-04-30 Kuros Biosciences to Propose Re-Appointment of Chairman and Board Members at Annual General Meeting
GlobeNewswire 2019-04-12 Kuros Biosciences Reports Results for the Full Year 2018
GlobeNewswire 2019-04-09 Kuros Biosciences Enters Convertible Bond Financing Agreement For Up To CHF 5 Million